£650K
The funding round includes participation from the LBA EIS Roundtable Syndicate Fund 2016 to support market growth.
The company manufactures clinical-grade electrospun biomaterials to support tissue repair and medical device development.
Oxfordshire-based developer of clinical-grade electrospun biomaterials designed for use in medical devices and tissue regeneration.
Cash at bank
Net current assets
Total assets less current liabilities
Net assets
Shareholders' funds
Fixed assets
Cash, assets and headcount from The Electrospinning Company's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Ann Kramer
CEO
The funding round includes participation from the LBA EIS Roundtable Syndicate Fund 2016 to support market growth.